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Background
Inherited cancer syndromes associated with acoustic neu-
roma (i.e. neurofibromatosis 2-NF2), pheochromocytoma
(i.e. Von Hippel Lindau, NFl, multiple endocrine neopla-
sia syndromes, and hereditary paraganglioma syndrome),
and colon cancer are well known. Lynch syndrome is the
most common hereditary colon cancer syndrome and is
caused by DNA mismatch repair dysfunction secondary
to inherited mutations in one of MLHl, MSH2, MSH6,
and less commonly PMS2. An increased risk for a variety
of cancers is seen in patients with Lynch syndrome with
the greatest risks being for colon and endometrial cancer.
We report a Dutch patient with a history of bilateral
acoustic neuromas diagnosed at 47, and pheochromocy-
toma and endometrial adenocarcinoma diagnosed at age
54. She had no family history or other signs/symptoms
of NF2. Family history was significant for her brother
having metachronous colon cancers at 42 and 51, and a
maternal uncle having colon cancer in his 40s. The family
does not fulfill either Amsterdam I or II criteria.
Methods
Clinical investigations for hereditary cancer predisposi-
tion were undertaken in our patient given her history of
multiple primary tumors. Immunohistochemistry (IHC)
for MLH1, MSH2, and MSH6 proteins, and genetic test-
ing for Lynch syndrome were completed. In light of the
history of bilateral acoustic neuromas, genetic testing
for NF2 was also undertaken.
Results
Genetic testing for NF2 did not detect a mutation
or deletion in the NF2 gene. IHC on tissue from
the patient’s endometrial adenocarcinoma and pheochro-
mocytoma showed absent expression of MSH6. A
pathogenic germline mutation in MSH6 (c.651_652insT)
was identified.
Conclusions
We report a potential new association of Lynch syn-
drome with pheochromocytoma and acoustic neuromas
in a woman with Lynch syndrome caused by an MSH6
mutation. In this case, a diagnosis of Lynch syndrome
was suspected due the history of endometrial adenocarci-
noma in our patient and her family history of early colon
cancer. Identification of a Dutch founder mutation in
MSH6 confirmed the diagnosis. The absence of MSH6
expression by IHC in both the endometrial carcinoma
and the pheochromocytoma highly suggests an associa-
tion of the pheochromocytoma with defective mismatch
repair function secondary to the MSH6 mutation. Unfor-
tunately, tumor studies could not be completed on tissue
from the acoustic neuroma so it is difficult to say
whether they arose independently or were also related to
the diagnosis of Lynch syndrome. In this case, normal
NF2 genetic testing and the absence of a family history of
NF2 may suggest an association of acoustic neuromas
with Lynch syndrome.
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